BIOventures_logoR2.jpg
  • HOME

  • NEWS

  • ABOUT

    • Company
    • Mission
    • Research Team
  • TECHNOLOGY

  • PATENTS AND PUBLICATIONS

  • GRANTS

  • WE CARE

  • CONTACT

  • More

    Use tab to navigate through the menu items.

    Recent news

    Grant from The National Centre for Research and Development

    • Oct 1, 2021

    Bacteriophages of Thermophilic ‘Bacillus Group’Bacteria—A Review

    • Jul 1, 2021

    Positive initial animal trials of the recombinant anti-SARS-CoV-2 vaccine

    • Jun 20, 2021

    Archived news

    • October 2021 (1) 1 post
    • July 2021 (1) 1 post
    • June 2021 (1) 1 post
    • April 2021 (1) 1 post
    • March 2021 (1) 1 post
    • December 2020 (1) 1 post
    • November 2020 (1) 1 post
    • August 2020 (3) 3 posts
    • July 2020 (2) 2 posts
    • June 2020 (1) 1 post
    • May 2020 (1) 1 post
    • April 2020 (1) 1 post
    • March 2020 (1) 1 post
    • December 2019 (1) 1 post
    • November 2019 (2) 2 posts
    • August 2018 (1) 1 post
    • April 2018 (1) 1 post
    • December 2017 (1) 1 post
    • November 2017 (1) 1 post
    • October 2017 (1) 1 post
    • August 2017 (1) 1 post
    • July 2017 (2) 2 posts
    • January 2017 (1) 1 post
    • November 2016 (1) 1 post
    • February 2016 (2) 2 posts
    • October 2015 (2) 2 posts
    • June 2015 (1) 1 post
    • April 2015 (1) 1 post
    • March 2015 (1) 1 post
    • October 2014 (1) 1 post
    • July 2014 (1) 1 post
    • January 2014 (1) 1 post
    • December 2013 (1) 1 post
    • August 2013 (1) 1 post
    • June 2013 (1) 1 post
    • October 2012 (1) 1 post
    • April 2012 (1) 1 post
    • March 2012 (1) 1 post
    • November 2011 (1) 1 post
    • Apr 20, 2015

    New patent application

    BioVentures Institute Sp. z o.o. filed an international patent application (PCT). Title of application: „A method of obtaining a polyepitopic protein as well as a DNA vector for embodying this method”, describing a novel technology for the construction of artificial polyepitopic proteins, applied to construct recombinant vaccines, among other applications. The application received positive verification from the PCT International Search Report no WO 2015/162560 A1.
    MaaS™ - MOLECULES AS A SERVICE

    © BioVentures Institute 2020

    • HOME

    • NEWS

    • ABOUT

      • Company
      • Mission
      • Research Team
    • TECHNOLOGY

    • PATENTS AND PUBLICATIONS

    • GRANTS

    • WE CARE

    • CONTACT

    • More

      Use tab to navigate through the menu items.

      TERMS

      PRIVACY